AST test results are given in units per liter. A level over 40 units per liter can mean a fatty liver or other liver disease, though it is not conclusive. Your doctor will order further tests to determine if a
血清AST水平与非酒精性脂肪性肝病的进展性肝纤维化有关 万方数据
A study compared multiple models (including AST/ALT ratio, APRI, FIB-4, nonalcoholic fatty liver disease (NAFLD) fibrosis score, and BARD) in 93 NASH, and the FIB-4 score had the best diagnostic accuracy for advanced fibrosis (AUROC = 0.86) [19]. A meta-analysis found that the AUROC ...
The more alcohol consumed, or the higher the level of alcohol in the blood, the more damage is done. The most important factor is the frequency, and the number of years spent drinking. The following are how the destruction of the liver progresses: Fatty liver disease - the accumulation of...
Elevated AST or ALT to non-alcoholic fatty liver disease: accurate predictor of disease prevalence? Am J Gastroenterol. 2003;98:955-6.Yu A S,Keeffe E B.Elevated AST or ALT to nonalcoholic fatty liver disease: accurate predictor of disease prevalence. The American journal of Gastroenterology ....
Feere1, Alvin Tieu1, Andrew S. Kucey1, Polydoros Kyriacou2, Laura E. McCuaig1, Stephanie E. Nevison1, Michael A. Kerr2 & Bradley L. Urquhart1,3,4 Chronic kidney disease (CKD) results in the accumulation of metabolic waste products that are normally ...
Non-alcoholic fatty liver disease (NAFLD) without fibrosis or cirrhosis may be associated with an AST:ALT ratio below 1. The AST:ALT ratio is incorporated into a comprehensive NAFLD fibrosis score. A ratio of less than one is suggestive of NAFLD/non-alcoholic steatohepatitis. However, the ratio...
Since AST level will increase significantly after one consumes alcohol, it could also be a marker for alcohol consumption. However, it should be noted that most patients with high alcohol consumption but without severe liver disease often do not have an AST/ALT ratio abov...
8. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis[J].Nakajima; Atsushi;Sumida; Yoshio;Itoh; Yoshito,世界胃肠病学杂志(英文版).2014,第2期 9. Predictive value of serum Golgi protein 73 for prominent hep...
Understanding mechanisms of hepatocellular damage may lead to new treatments for liver disease, and genome-wide association studies (GWAS) of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) serum activities have proven useful for inve